"covid-19" scalable biosynthetic convalescent plasma (IMM-BCP-001)

Ended Other Transaction Agreement Awarded Last action

Contract number
W911QY2090019
Awardee
Awarding agency
Obligated
$17,598,323

Award facts

Contract value 100% obligated
$17,598,597.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other
Place of performance
Exton, PA 19341, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 · Prototype biosynthetic plasma -$274
Other Administrative Action P00004 · "covid-19" prototype covid treatment development $0
Other Administrative Action P00003 · "covid-19" no cost extension $0
Supplemental Agreement for work within scope P00002 · "covid-19" additional cost, schedule and performance due to FDA requirements. $4,297,626
Funding Only Action P00001 · "covid-19" funding action. $996,415
Original award $12,304,556

About this award

This contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Immunome, Inc., a self-certified small disadvantaged business, for a COVID-19 Scalable Biosynthetic Convalescent Plasma (IMM-BCP-001) project. The contract is an Other Transaction Agreement with a potential value of $17,598,597.00 and a completion date of July 31, 2023. The contract does not have a set-aside designation. The purpose of this contract is to deliver products and services related to the development of a scalable biosynthetic convalescent plasma for COVID-19.

Quick answers

Who was awarded contract W911QY2090019?

W911QY2090019 was awarded to Immunome, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on July 3, 2020.

How much is contract W911QY2090019 worth?

The government has obligated $17,598,323 on W911QY2090019. Its current value, with exercised options, is $17,598,597.

Which agency awarded contract W911QY2090019?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY2090019, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911QY2090019 competed?

The extent of competition for W911QY2090019 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award